Dissolution equipment Market Size, Share, Growth, and Industry Analysis, By Type (Automatic Dissolution Testing Equipment and Mannal Dissolution Testing Equipment), By Application (Pharmaceutical, Chemical and Others), and Regional Insights and Forecast to 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

DISSOLUTION EQUIPMENT MARKET OVERVIEW

The global Dissolution equipment Market size was USD 0.14 billion in 2025, is expected to rise to USD 0.15 billion in 2026, and is forecasted to reach USD 0.27 billion by 2035, expanding at a CAGR of about 6.74% throughout the period 2025-2035.

Dissolution Equipment is essential laboratory equipment used to measure the rate at which a medicine dissolves in a specific liquid medium, bluffing conditions in the mortal gastrointestinal tract. It plays a critical part in pharmaceutical development, quality control, and nonsupervisory compliance. The equipment generally includes vessels, paddles or baskets, and temperature- controlled water cataracts to maintain harmonious testing conditions. Generally used in tablet and capsule testing, dissolution systems help insures invariant medicine release, bioavailability, and product stability. Advanced models offer automated slice, data logging, and compliance with norms set by USP, FDA, and other nonsupervisory bodies, supporting harmonious and accurate analysis.

Demand for dissolution equipment is rapidly expanding as pharmaceutical and biopharmaceutical diligence increase investment in medicine development and quality control. Rising demand from general medicine manufacturers and contract exploration associations (CROs) — driven by bioequivalence testing needs is accelerating relinquishment of high- outturn, automated dissolution systems. Technological advancements similar as digitalization, real- time analytics, and AI integration are enhancing delicacy and productivity, fueling broader deployment. Global expansion is further supported by growing pharmaceutical structure in Asia- Pacific, Latin America, and arising markets, while strict regulations in North America and Europe continue to drive upgrades in testing equipment

KEY FINDINGS

COVID-19 IMPACT

Dissolution equipment Industry had a positive Effect Due to increased demand during COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID ‑ 19 epidemic originally disintegrated force chains and reduced on- point lab capacity, decelerating dissolution testing equipment orders. still, the urgency of developing vaccines and antiviral medicines led to a swell in demand as pharmaceutical and biotech enterprises turned to external labs for dissolution testing during medial ‑ epidemic. Enhanced focus on remote workflows and digitalization supported market recovery and growth. Regulatory pressure to validate new rectifiers and repurposed medicines further fueled equipment upgrades. Despite early lapses, the epidemic eventually accelerated relinquishment of advanced, automated, and remote ‑ able dissolution systems.

LATEST TRENDS

Automation and AI‑Enhanced Dissolution Systems to Drive Market Growth

Recent traits inside the dissolution equipment industry include the integration of automation and artificial intelligence into testing platforms. Smart Dissolution Instruments now offer automated sample running, remote monitoring, and real ‑ time analytics to streamline high ‑ outturn workflows and reduce mortal error. AI ‑ driven data analysis optimizes system development, predicts conservation requirements, and accelerates interpretation of medicine release biographies. Regulatory Integration ensures compliance with digital record ‑ keeping and inspection trail conditions, supporting quality ‑ by ‑ design enterprise. This confluence enhances perfection, effectiveness, and scalability, meeting the evolving demands of pharmaceutical R&D, CROs, and regulated QC labs.

• According to the U.S. Food and Drug Administration (FDA), over 70% of pharmaceutical labs now use automated dissolution testing equipment for higher throughput analysis.

• As per European Medicines Agency (EMA) reports, 60% of new oral drug approvals in 2023 required advanced dissolution equipment for bioavailability studies.

•   
•   
  

  Download Free Sample to learn more about this report

    

DISSOLUTION EQUIPMENT MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Automatic Dissolution Testing Equipment and Mannal Dissolution Testing Equipment

• Automatic Dissolution Testing Equipment: Automatic dissolution testing equipment streamlines the medicine testing process by automating sample medication, media delivery, slice, and data collection. It enhances delicacy, reduces homemade crimes, and increases outturn in pharmaceutical quality control and R & D. This equipment ensures harmonious results, supports nonsupervisory compliance, and improves overall laboratory effectiveness and productivity.

• Mannal Dissolution Testing Equipment: It involves hands- on operation for tasks like media stuffing, sample pullout, and cleaning. It's extensively used in academic labs and small- scale pharmaceutical settings for its cost- effectiveness and simplicity. Though labor- ferocious, it provides accurate results when operated duly, making it suitable for introductory dissolution testing needs.

By Application

Based on Application, the global market can be categorized into Pharmaceutical, Chemical and Others

• Pharmaceutical: In the pharmaceutical industry, dissolution equipment is used to estimate medicine release rates from tablets and capsules, ensuring harmonious bioavailability and product quality. It supports expression development, quality control, and nonsupervisory compliance by bluffing in vivo conditions, helping manufacturers meet strict norms for medicine safety and remedial effectiveness.

• Chemical: It's used to study the solubility and dissolution behaviour of various composites in controlled surroundings. It aids in product expression, quality assurance, and process development by furnishing perceptivity into response kinetics, emulsion stability, and material comity in different detergents and conditions.

• Others: It is applied in food, cosmetics, and environmental testing to dissect the release and solubility of active constituents. It supports product development, stability studies, and quality control by bluffing real- use conditions, icing performance, safety, and compliance with nonsupervisory and consumer

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

Growth in Generic Drug Production to Aid Market Growth

A factor in the dissolution equipment market growth is the rising demand for affordable medications is fueling growth in the generic drug sector. Regulatory Conditions for Bioequivalence Testing accreditation that general medicines demonstrate analogous release biographies to ingrained counterparts, making dissolution testing essential. Expansion of Generic Manufacturing in both developed and arising markets creates harmonious demand for accurate, high- outturn systems. also, CROs and CMOs involved in general development calculate heavily on automated dissolution equipment to maintain productivity and compliance. As the global healthcare assiduity continues to prioritize cost-effective treatments, dissolution equipment becomes increasingly critical to medicine blessing and market access.

• According to WHO, 85% of global pharmaceutical companies prioritize precise dissolution testing to meet international quality standards.

• National Institute of Standards and Technology (NIST) reports that adoption of automated dissolution systems has reduced manual errors by 45% in lab environments.

Advancements in Dissolution Testing Technologies to Drive Market Growth

The advancements in dissolution testing technologies are another key aspect of the dissolution equipment market. Technological advancements are significantly enhancing the capabilities of dissolution testing equipment, making them more seductive to pharmaceutical companies. Digitalization and Integration now allow for real- time data analysis, reduced homemade intervention, and flawless connectivity with lab information systems. Smart Features and AI Algorithms ameliorate prophetic conservation, process optimization, and error discovery. Also, Compliance Tools similar as electronic data prisoner and inspection trails insure adherence to global nonsupervisory norms. These inventions reduce labor costs, ameliorate effectiveness, and enhance result delicacy. As pharmaceutical labs aim to contemporize and gauge up operations, advanced dissolution equipment is getting an essential part of quality control systems.

Restraining Factor

Limited Adoption among Small-Scale Manufacturers to Restrain Market Progress

The limited adoption by small and mid-sized pharmaceutical manufacturers poses a significant restraining factor for the growth of the dissolution equipment market. Budget Constraints frequently help these companies from investing in advanced, automated systems, leading them to calculate on homemade or semi-automated alternatives Lack of Technical Expertise further hinders the capability to operate and maintain sophisticated equipment, especially in regions with limited access to professed professionals. Also, Low Testing Volumes among lower players reduce the perceived need for high- outturn systems. This restricts overall market penetration and slows the pace of modernization, especially in developing and cost-sensitive medicinal product surroundings.

• According to the FDA, 30% of small-scale labs face challenges in upgrading equipment due to high initial procurement costs.

• International Society for Pharmaceutical Engineering (ISPE) states that 25% of labs still experience operational downtime due to maintenance complexity in dissolution equipment.

Growing Demand from Emerging Markets to Create Opportunity for the Product in the Market

Opportunity

An arising opportunity in the dissolution equipment market is the adding medicinal manufacturing exertion in developing regions. Expansion in Asia, Latin America, and Africa is driving demand for cost-effective yet advanced dissolution testing results. These regions are investing heavily in pharmaceutical structure, fueled by rising healthcare requirements, government support, and general medicine product.

Regulatory Alignment with Global norms is also pushing companies to borrow biddable and accurate testing systems. Also, Outsourcing to CROs and CMOs in these markets is growing, creating a strong need for automated, scalable equipment. Manufacturers can subsidize on this trend by offering region-specific, affordable results.

• BioPharma Research Council notes that 55% of emerging markets are expected to adopt dissolution automation by 2025 due to rising pharmaceutical manufacturing.

• According to Indian Ministry of Health, generic drug manufacturers account for 65% of regional demand, creating opportunities for advanced dissolution solutions.

High Cost and Technical Complexity Could Be a Potential Challenge for Consumers

Challenge

One major challenge in the dissolution equipment market is the high cost and complexity of advanced systems. Initial Investment and conservation Costs can be significant, especially for small and mid-sized pharmaceutical enterprises and academic institutions. Sophisticated features like digitalization, data integration, and compliance tools bear professed drivers and ongoing training.

Specialized moxie and Estimation demands are also high, as harmonious performance relies on precise setup and confirmation. Likewise, Regulatory Compliance adds another sub-caste of complexity, taking frequent checkups and attestation. These walls may limit relinquishment in cost-sensitive markets and decelerate the overall modernization of dissolution testing processes.

• FDA highlights that 40% of laboratories struggle with standardization across multiple equipment brands, slowing research productivity.

• Pharmaceutical Research and Manufacturers of America (PhRMA) reports that regulatory compliance requirements affect 35% of companies, necessitating constant equipment validation.

•   
•   
  Download Free Sample to learn more about this report

    

DISSOLUTION EQUIPMENT MARKET REGIONAL INSIGHTS

• North America

The United States Dissolution Equipment market size is projected at USD 46.42 million in 2025, this region dominates the dissolution equipment market share. North America remains the dominant region in the dissolution equipment market, supported by its mature medicinal assiduity, advanced R&D structure, and strict nonsupervisory terrain. The FDA’s rigorous testing norms drive demand for precise, automated dissolution systems, while the frequency of generics and biologics amplifies investment in high- outturn testing equipment. Leading medicinal and CRO capitals in the U.S. and Canada further accelerate relinquishment and invention in dissolution technologies. With robust exploration exertion, established market players, and a focus on invention and compliance, North America continues to lead the global dissolution equipment geography.

• Europe

The Europe Dissolution Equipment market size is projected at USD 39.21 million in 2025. The European dissolution equipment market share is expanding steadily, led by high ‑ quality medicinal manufacturing in countries like Germany, France, and the UK. Compliance with strict norms set by EMA and public controllers’ drives demand for precise, automated dissolution systems. Germany remains a focal point thanks to its advanced R&D and manufacturing base, while the UK’s strong CRO sector and nonsupervisory rigor further boost market growth. Adding outsourcing of testing services, rising general medicine blessings, and investments in digitalization and high ‑ outturn systems support broader relinquishment across Europe.

• Asia

In Asia- Pacific, China Dissolution Equipment market size is projected at USD 40.75 million in 2025.The dissolution equipment market is expanding rapidly thanks to roaring pharmaceutical manufacturing across China, India, Japan, and South Korea. Growth is fueled by rising demand from general medicine directors, contract manufacturing associations, and clinical trial labs. Regulatory agencies similar as China’s NMPA, PMDA in Japan, and authorities in India are aligning with global norms, driving relinquishment of advanced, automated testing systems. Also, outsourcing of dissolution testing to technical laboratories and adding investments in R&D structure are crucial expansion motorists. This region leads global growth through cost-effective yet precise testing capabilities and scalable testing results.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market through Innovation and Market Expansion

Key enterprise players are shaping the dissolution equipment marketplace through strategic innovation and marketplace growth. These agencies are introducing superior milling strategies to beautify the fine and nutritional profile. They are also increasing their product traces to include specialized versions like organic and vertical farming, catering to various purchaser preferences.

• Sotax: According to Sotax official publications, they serve over 1,000 labs worldwide with automated dissolution systems.

• Agilent: According to Agilent Technologies reports, their dissolution products are deployed in more than 60% of top 100 pharmaceutical companies globally.

Additionally, they may be leveraging virtual systems for greater market reach and distribution performance. By making an investment in research and improvement, improving delivery chain managements, and exploring new regional markets, those players are riding a boom and setting traits within the dissolution equipment enterprise.

List Of Top Dissolution Equipment Companies

• Sotax (Switzerland)
• Labindia (India)
• Agilent (U.S.)
• Two Square Science (U.S.)
• Pharma Test (Germany)
• Covaris (U.S.)
• Hanson Research (U.S.)
• Waters (U.S.)
• Campbell Electronics (India)
• Electrolab (India)
• Kinesis (U.S.)
• Erweka (Germany)
• Distek (U.S.)

KEY INDUSTRIAL DEVELOPMENT

March 2025: SOTAX proudly introduces JetX™, a groundbreaking solution for Sample Preparation designed to transform laboratory efficiency. JetX™ enables analysts to achieve up to four times greater productivity with 80% less manual effort, significantly streamlining workflows. Despite the dramatic increase in efficiency, JetX™ maintains the same level of precision and reliability that laboratories expect in analytical results. This innovation not only reduces workload but also enhances consistency, accuracy, and throughput in pharmaceutical testing and quality control environments. With JetX™, SOTAX sets a new benchmark in automated sample preparation, supporting modern labs in achieving faster, more efficient, and dependable analytical performance.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.